Evidence map›Paper›PMID 26207309›Full record

ArticleInvestigative ophthalmology & visual science2015

Targeting Caspase-12 to Preserve Vision in Mice With Inherited Retinal Degeneration.

Yogesh Bhootada, Shreyasi Choudhury, Clark Gully, Marina Gorbatyuk

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Exploring caspase functions in mouse models.Apoptosis : an international journal on programmed cell death · 2024
    Review
  3. Review
  4. Gene Therapy for Rhodopsin Mutations.Cold Spring Harbor perspectives in medicine · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yogesh BhootadaDepartment of Vision Sciences University of Alabama at Birmingham, Birmingham, Alabama, United States.
Shreyasi ChoudhuryDepartment of Cell Biology and Anatomy, University of North Texas Health Science Center, North Texas Eye Research Institute, Fort Worth, Texas, United States.
Clark GullyDepartment of Vision Sciences University of Alabama at Birmingham, Birmingham, Alabama, United States.
Marina GorbatyukDepartment of Vision Sciences University of Alabama at Birmingham, Birmingham, Alabama, United States.
University of Alabama at Birmingham · USUniversity of North Texas · US

Funding

Unfolded Protein Response as a Therapeutic Target for ADRP Animal ModelsR01EY020905 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI GORBATYUK, MARINA · 2010 to 2014
$1.3M
NEI NIH HHS R01 EY020905NEI NIH HHS R01EY020905
6 · The paper itself

Abstract

purposeThe unfolded protein response is known to contribute to the inherited retinal pathology observed in T17M rhodopsin (T17M) mice. Recently it has been demonstrated that the endoplasmic reticulum stress-associated caspase-12 is activated during progression of retinal degeneration in different animal models. Therefore, we wanted to explore the role of caspase-12 in the mechanism of retinopathy in T17M mice and determine if inhibiting apoptosis in this way is a viable approach for halting retinal degeneration.

methodsOne, two-, and three-month-old C57BL6/J, caspase-12-/-, T17M, and T17M caspase-12-/- mice were analyzed by scotopic ERG, spectral-domain optical coherence tomography (SD-OCT), histology, quantitative (q)RT-PCR, and Western blot of retinal RNA and protein extracts. Calpain and caspase-3/7 activity assays were measured in postnatal (P) day 30 retinal extracts.

resultsCaspase-12 ablation significantly prevented a decline in the a- and b-wave ERG amplitudes in T17M mice during three months, increasing the amplitudes from 232% to 212% and from 160% to 138%, respectively, as compared to T17M retinas. The SD-OCT results and photoreceptor row counts demonstrated preservation of retinal structural integrity and postponed photoreceptor cell death. The delay in photoreceptor cell death was due to significant decreases in the activity of caspase-3/7 and calpain, which correlated with an increase in calpastatin expression.

conclusionsWe validated caspase-12 as a therapeutic target, ablation of which significantly protects T17M photoreceptors from deterioration. Although the inhibition of apoptotic activity alone was not sufficient to rescue T17M photoreceptors, in combination with other nonapoptotic targets, caspase-12 could be used to treat inherited retinopathy.

Indexed as

Gene Expression RegulationAnimalsApoptosisBlotting, WesternCaspase 12Disease Models, AnimalElectroretinographyFemaleMaleMiceMice, Inbred C57BLReal-Time Polymerase Chain ReactionRetinaRetinal DegenerationRNATomography, Optical CoherenceCasp12 protein, mouseCaspase 12RNA

Identifiers

PMID26207309
PMCPMC4516015
OpenAlexW1554887155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.